and one of the first producers of CBG under the Sustainable Alternative Towards Affordable Transportation (“SATAT”) scheme has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to raise capital through an Initial Public Offering (IP...
Cyclone Dana LandfallHyundai Share PricePam Kaur Bangalore Weather UpdateColdplay Ticket RowAdar Poonawala Dharma Productions News by Industry FEATURED AUTO BANKING / FINANCE CONS. PRODUCTS ENERGY RENEWABLES IND'L GOODS / SVS INTERNET HEALTHCARE JOBS RETAIL SERVICES RISE MEDIA TECH TELECOM TRANSPORTATION ...
| Max Healthcare | Oil India | Oracle Financial Services Software | Olectra Greentech | Procter & Gamble Health | SBI | Sun Pharma | The Phoenix Mills | Thermax | Trent Ltd | Triveni Turbine | UCO Bank | Varun Beverages | Yes Bank | Zee Entertainment | Zomato Ltd | Zydus Lifesciences...
Mylan N.V., Dr. Reddy’s Laboratories Ltd, Zydus Cadila, LUPIN, Torrent Pharmaceuticals Ltd, Jubilant Life Sciences Ltd, Alembic Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC,
| Max Healthcare | Oil India | Oracle Financial Services Software | Olectra Greentech | Procter & Gamble Health | SBI | Sun Pharma | The Phoenix Mills | Thermax | Trent Ltd | Triveni Turbine | UCO Bank | Varun Beverages | Yes Bank | Zee Entertainment | Zoma...
February 2023: Zydus Lifesciences Limited received tentative approval from the USFDA for Invokamet tablets (canagliflozin and metformin hydrochloride combination). Canagliflozin and metformin combination products are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type...
In July 2022, Zydus Lifesciences announced that it had received final approval from the USFDA to market Empagliflozin and Metformin Hydrochloride tablets in multiple strengths. Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults ...
In January 2023 - Zydus Lifesciences established Topiramate extended-release capsules, a generic medication for treating epilepsy in the United States market. In March 2022 - Lupin's abbreviated new Vigabatrin application (ANDA), an antiepileptic drug available as an oral solution USP (500 mg), re...
Zydus Lifesciences Limited Sorrento Therapeutics, Inc Amneal Pharmaceuticals LLC Abbott Laboratories REPORT DESCRIPTION Sciatica is a state where pain causes, which travels along the path of the sciatic nerve and leads to pain in the back, buttocks, and legs. The pain commonly begins in the lower...
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for addi...